Auspex Pharmaceuticals Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 37

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $3.5B

Auspex Pharmaceuticals General Information

Description

Developer of deuterated analogs of clinically-validated drugs. The company develops a pipeline of therapeutics that improves on existing drugs across various therapeutic areas. It focuses on the development of drugs for the treatment of involuntary movement disorders, respiratory disease and inflammation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Corporate Office
  • 3366 North Torrey Pines Court
  • Suite 225
  • San Diego, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Auspex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 05-May-2015 $3.5B 00000 00.00 Completed Clinical Trials - Phase 3
15. 2PO 23-Jan-2015 00000 00000 Completed Clinical Trials - Phase 3
14. 2PO 11-Jul-2014 000.00 00000 00000 Completed Clinical Trials - Phase 3
13. IPO 05-Feb-2014 0000 00000 00000 Completed Clinical Trials - Phase 3
12. Debt - General 08-Jan-2014 0000 00000 Completed Clinical Trials - Phase 3
11. Later Stage VC (Series E) 20-Dec-2013 000.00 00000 00000 Completed Clinical Trials - Phase 3
10. Later Stage VC (Series D) 06-Sep-2013 0000 0000 000.00 Completed Clinical Trials - Phase 3
9. Debt - General 11-Mar-2013 0000 Completed Clinical Trials - Phase 3
8. Later Stage VC 09-Nov-2012 $19M $70M Completed Clinical Trials - Phase 3
7. Later Stage VC 28-Dec-2011 $3M $51M Completed Generating Revenue
To view Auspex Pharmaceuticals’s complete valuation and funding history, request access »

Auspex Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A5 00,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A4 000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A3 000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A2 610,294 $0.000100 8% $1.7 $1.7 1x $1.7 0.87%
Series A1 613,500 $0.000100 8% $1 $1 1x $1 0.88%
To view Auspex Pharmaceuticals’s complete cap table history, request access »

Auspex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of deuterated analogs of clinically-validated drugs. The company develops a pipeline of therapeutics that impr
Drug Discovery
San Diego, CA
37 As of 2014
00000
00.00 0000-00-00
000000&0 00000

000000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000 000000000
San Diego, CA
000 As of 0000
00000
00000000000 00000

000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000 000000000
Boston, MA
0000 As of 0000
00.000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Auspex Pharmaceuticals Competitors (83)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biosplice Therapeutics Private Equity-Backed San Diego, CA 000 00000 00000000000 00000
Vertex Pharmaceuticals Formerly VC-backed Boston, MA 0000 00.000 000000&0
Rhythm Pharmaceuticals Formerly VC-backed Boston, MA 000 00000 000000000 00000
Stealth BioTherapeutics Private Equity-Backed Needham, MA 00 00000 000000000000 00000
Pharmacyclics Formerly VC-backed Sunnyvale, CA 000 000.00 000000&0 000.00
You’re viewing 5 of 83 competitors. Get the full list »

Auspex Pharmaceuticals Patents

Auspex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022346033-A1 Multiparticulate dosage forms comprising deutetrabenazine Pending 17-Sep-2021 0000000000
CA-3231490-A1 Multiparticulate dosage forms comprising deutetrabenazine Pending 17-Sep-2021 0000000000
EP-4225269-A1 Gastro retentive dosage forms comprising deutetrabenazine Pending 12-Oct-2020 0000000000
AU-2021362683-A1 Gastro retentive dosage forms comprising deutetrabenazine Pending 12-Oct-2020 0000000000
US-20230390192-A1 Gastro retentive dosage forms comprising deutetrabenazine Pending 12-Oct-2020 A61K9/0065
To view Auspex Pharmaceuticals’s complete patent history, request access »

Auspex Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Auspex Pharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioMed Ventures Corporate Venture Capital Minority 000 0000 000000 0
Costa Verde Capital Venture Capital Minority 000 0000 000000 0
Deerfield Management Venture Capital Minority 000 0000 000000 0
Foresite Capital Growth/Expansion Minority 000 0000 000000 0
Panorama Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Auspex Pharmaceuticals FAQs

  • When was Auspex Pharmaceuticals founded?

    Auspex Pharmaceuticals was founded in 2001.

  • Who is the founder of Auspex Pharmaceuticals?

    Manouchehr Shahbaz Ph.D is the founder of Auspex Pharmaceuticals.

  • Where is Auspex Pharmaceuticals headquartered?

    Auspex Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Auspex Pharmaceuticals?

    Auspex Pharmaceuticals has 37 total employees.

  • What industry is Auspex Pharmaceuticals in?

    Auspex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Auspex Pharmaceuticals a private or public company?

    Auspex Pharmaceuticals is a Private company.

  • What is the current valuation of Auspex Pharmaceuticals?

    The current valuation of Auspex Pharmaceuticals is 00.00.

  • What is Auspex Pharmaceuticals’s current revenue?

    The current revenue for Auspex Pharmaceuticals is 000000.

  • How much funding has Auspex Pharmaceuticals raised over time?

    Auspex Pharmaceuticals has raised $493M.

  • Who are Auspex Pharmaceuticals’s investors?

    BioMed Ventures, Costa Verde Capital, Deerfield Management, Foresite Capital, and Panorama Capital are 5 of 9 investors who have invested in Auspex Pharmaceuticals.

  • Who are Auspex Pharmaceuticals’s competitors?

    Biosplice Therapeutics, Vertex Pharmaceuticals, Rhythm Pharmaceuticals, Stealth BioTherapeutics, and Pharmacyclics are some of the 83 competitors of Auspex Pharmaceuticals.

  • When was Auspex Pharmaceuticals acquired?

    Auspex Pharmaceuticals was acquired on 05-May-2015.

  • Who acquired Auspex Pharmaceuticals?

    Auspex Pharmaceuticals was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »